Title : Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study).

Pub. Date : 2022 Mar 21

PMID : 35307033






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Individuals with higher body mass index, type 2 diabetes, insulin resistance, and severe liver fibrosis were likely to be good responders to treatment with ezetimibe. Ezetimibe insulin Homo sapiens